Cancer treatment has evolved significantly with the introduction of targeted therapies, offering better outcomes and improved quality of life for patients. Axitinib Tablets 1 mg & 5 mg have emerged as an effective treatment option for patients suffering from advanced renal cell carcinoma (RCC), the most common type of kidney cancer.
Cordium Pharmaceuticals Pvt Ltd is a trusted global pharmaceutical company engaged in manufacturing and exporting high-quality oncology medicines, including Axitinib Tablets, to international markets.
What is Axitinib?
Axitinib is a targeted anti-cancer medicine belonging to the class of Tyrosine Kinase Inhibitors (TKIs).
It works by blocking proteins called vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, and VEGFR-3) that help tumors develop new blood vessels. By inhibiting blood supply, Axitinib slows down or stops cancer growth.
Medical Uses of Axitinib Tablets
Axitinib is prescribed for:
Advanced Renal Cell Carcinoma (Kidney Cancer)
Second-line treatment after prior therapy failure
Combination therapy with immunotherapy medicines
Metastatic kidney cancer treatment
Doctors may also recommend it in personalized cancer treatment protocols.
Available Strengths
Axitinib Tablets 1 mg
Used for:
Dose adjustments
Patients sensitive to higher doses
Personalized treatment plans
Axitinib Tablets 5 mg
Used for:
Standard maintenance therapy
Advanced RCC treatment protocols
Combination oncology treatments
How Does Axitinib Work?
Axitinib targets cancer growth by:
✅ Blocking VEGF receptors
✅ Reducing blood vessel formation (anti-angiogenesis)
✅ Limiting tumor oxygen supply
✅ Slowing cancer progression
✅ Supporting long-term disease management
Benefits of Axitinib Tablets
Precision Targeted Therapy
Unlike traditional chemotherapy, Axitinib specifically attacks cancer pathways.
Improved Patient Outcomes
Many patients experience delayed disease progression and improved survival rates.
Oral Administration
Convenient tablet form reduces hospital visits.
Personalized Dosing
Available in multiple strengths for individualized treatment.
Global Standard of Care
Widely prescribed by oncologists worldwide.
Recommended Dosage
Always use under the supervision of an oncologist.
Typical dosage:
Initial dose: 5 mg twice daily
Dose adjustments may be increased or reduced
Tablets should be taken approximately 12 hours apart
Swallow whole with water
Can be taken with or without food
Do not self-medicate.
Possible Side Effects
Common side effects include:
High blood pressure
Fatigue
Diarrhea
Nausea
Decreased appetite
Weight loss
Hoarseness
Hand-foot syndrome
Mouth sores
Seek immediate medical attention for severe symptoms.
Who Should Use Axitinib Carefully?
Consult your doctor if you have:
Liver disease
Heart disease
Uncontrolled hypertension
Bleeding disorders
Thyroid disorders
Recent surgery
Pregnant or breastfeeding women should avoid this medicine unless prescribed by a physician.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is committed to delivering affordable, high-quality oncology medicines globally.
Our Advantages
✔ WHO-GMP compliant manufacturing
✔ International export expertise
✔ Stringent quality control
✔ Competitive pricing
✔ Timely global delivery
✔ Regulatory support
✔ Bulk supply capabilities
Countries We Serve
Cordium Pharmaceuticals Pvt Ltd supplies Axitinib Tablets to:
Kenya
Nigeria
Ghana
Philippines
Vietnam
United Arab Emirates
Saudi Arabia
Uzbekistan
Kazakhstan
United States
United Kingdom
South Africa
Frequently Asked Questions (FAQs)
Is Axitinib chemotherapy?
No. Axitinib is a targeted therapy medicine, not conventional chemotherapy.
What cancer does Axitinib treat?
It is primarily used to treat advanced renal cell carcinoma (kidney cancer).
Is Axitinib available in 1 mg and 5 mg strengths?
Yes. Axitinib is commonly available in both 1 mg and 5 mg tablet strengths.
Can Axitinib be used with immunotherapy?
Yes. Oncologists may prescribe Axitinib in combination with immunotherapy medicines.
Is a prescription required?
Yes. Axitinib is a prescription-only anti-cancer medicine and must be used under specialist supervision.
xitinib Tablets 1 mg & 5 mg represent an important advancement in the treatment of advanced kidney cancer. With its targeted mechanism, oral convenience, and proven effectiveness, it has become a preferred choice among oncologists worldwide.
Cordium Pharmaceuticals Pvt Ltd continues to expand access to high-quality oncology medicines across Africa, Asia, the Middle East, Europe, and North America, helping improve patient outcomes globally.
